A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614)
Article in Pediatric Blood & Cancer (March 2024)
The most recent citing publications are shown below. View all 90 publications that cite this research output on Dimensions.
Article in Pediatric Blood & Cancer (March 2024)
Article in European Journal of Pharmacology (July 2023)
Article in Biochemical Genetics (July 2023)